Literature DB >> 23365440

Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.

Jingshan Zhang1, Howard L Lipton, Alan S Perelson, Harel Dahari.   

Abstract

Theiler murine encephalomyelitis virus (TMEV) infection of a mouse's central nervous system is biphasic: first the virus infects motor neurons (acute phase), and this is followed by a chronic phase in which the virus infects glial cells (primarily microglia and macrophages [M]) of the spinal cord white matter, leading to inflammation and demyelination. As such, TMEV-induced demyelinating disease in mice provides a highly relevant experimental animal model for multiple sclerosis. Mathematical models have proven valuable in understanding the in vivo dynamics of persistent virus infections, such as HIV-1, hepatitis B virus, and hepatitis C virus infections. However, viral dynamic modeling has not been used for understanding TMEV infection. We constructed the first mathematical model of TMEV-host kinetics during acute and early chronic infections in mice and fit measured viral kinetic data with the model. The data fitting allowed us to estimate several unknown parameters, including the following: the rate of infection of neurons, 0.5 × 10(-8) to 5.6 × 10(-8) day(-1); the percent reduction of the infection rate due to the presence of virus-specific antibodies, which reaches 98.5 to 99.9% after day 15 postinfection (p.i.); the half-life of infected neurons, 0.1 to 1.2 days; and a cytokine-enhanced macrophage source rate of 25 to 350 M/day into the spinal cord starting at 10.9 to 12.9 days p.i. The model presented here is a first step toward building a comprehensive model for TMEV-induced demyelinating disease. Moreover, the model can serve as an important tool in understanding TMEV infectious mechanisms and may prove useful in evaluating antivirals and/or therapeutic modalities to prevent or inhibit demyelination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365440      PMCID: PMC3624189          DOI: 10.1128/JVI.03395-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

3.  Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.

Authors:  Vanessa Herder; Ingo Gerhauser; Stephanie Kristin Klein; Pedro Almeida; Maren Kummerfeld; Reiner Ulrich; Frauke Seehusen; Karl Rohn; Dirk Schaudien; Wolfgang Baumgärtner; Jochen Huehn; Andreas Beineke
Journal:  J Neuroimmunol       Date:  2012-05-14       Impact factor: 3.478

Review 4.  Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes.

Authors:  Howard L Lipton; A S Manoj Kumar; Mark Trottier
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

5.  HIV dynamics with multiple infections of target cells.

Authors:  Narendra M Dixit; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

6.  High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus.

Authors:  M Trottier; P Kallio; W Wang; H L Lipton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Theiler's virus-induced intrinsic apoptosis in M1-D macrophages is Bax mediated and restricts virus infectivity: a mechanism for persistence of a cytolytic virus.

Authors:  Kyung-No Son; Robert P Becker; Patricia Kallio; Howard L Lipton
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis.

Authors:  M L Jelachich; H L Lipton
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

View more
  6 in total

1.  Advances in Parameter Estimation and Learning from Data for Mathematical Models of Hepatitis C Viral Kinetics.

Authors:  Vladimir Reinharz; Alexander Churkin; Harel Dahari; Danny Barash
Journal:  Mathematics (Basel)       Date:  2022-06-19

2.  Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.

Authors:  Vladimir Reinharz; Harel Dahari; Danny Barash
Journal:  Math Biosci       Date:  2018-03-15       Impact factor: 2.144

Review 3.  Viral kinetic modeling: state of the art.

Authors:  Laetitia Canini; Alan S Perelson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-06-25       Impact factor: 2.745

4.  Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection.

Authors:  Charles L Howe; Reghann G LaFrance-Corey; Emma N Goddery; Renee K Johnson; Kanish Mirchia
Journal:  J Neuroinflammation       Date:  2017-12-04       Impact factor: 8.322

5.  A Robust and Efficient Numerical Method for RNA-Mediated Viral Dynamics.

Authors:  Vladimir Reinharz; Alexander Churkin; Harel Dahari; Danny Barash
Journal:  Front Appl Math Stat       Date:  2017-10-31

6.  Serum Cytokines Predict Neurological Damage in Genetically Diverse Mouse Models.

Authors:  Aracely A Pérez Gómez; Moumita Karmakar; Raymond J Carroll; Koedi S Lawley; Katia Amstalden; Colin R Young; David W Threadgill; C Jane Welsh; Candice Brinkmeyer-Langford
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.